APM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aptorum Group Ltd Class A

NASDAQ | APM

1.44

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 3, 2025)

$11.73M

Market Cap

-

P/E Ratio

-0.34

EPS

$4.47

52 Week High

$0.46

52 Week Low

HEALTHCARE

Sector

APM Chart

Recent Chart
Price Action

APM Technicals

Tags:

APM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$255K
Total Revenue $0
Cost Of Revenue $255K
Costof Goods And Services Sold $255K
Operating Income -$3.8M
Selling General And Administrative $1.5M
Research And Development $1.9M
Operating Expenses $3.5M
Investment Income Net -
Net Interest Income -$147K
Interest Income -
Interest Expense $147K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $255K
Income Before Tax -$4.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$4.2M
Comprehensive Income Net Of Tax -
Ebit -$4M
Ebitda -$3.8M
Net Income -$4.3M

Revenue & Profitability

Earnings Performance

APM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $16M
Total Current Assets $960K
Cash And Cash Equivalents At Carrying Value $874K
Cash And Short Term Investments $874K
Inventory -
Current Net Receivables $4.5K
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $15M
Short Term Investments -
Other Current Assets $81K
Other Non Current Assets -
Total Liabilities $4.4M
Total Current Liabilities $4.3M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $3.3M
Total Non Current Liabilities $14K
Capital Lease Obligations $116K
Long Term Debt -
Current Long Term Debt $3.2M
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.4M
Other Current Liabilities $998K
Other Non Current Liabilities -
Total Shareholder Equity $21M
Treasury Stock -
Retained Earnings -$72M
Common Stock $55
Common Stock Shares Outstanding $5.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $255K
Capital Expenditures $0
Change In Receivables -
Change In Inventory $0
Profit Loss -
Cashflow From Investment $59K
Cashflow From Financing $1.4K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$4.3M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$255K
Total Revenue $0
Cost Of Revenue $255K
Costof Goods And Services Sold $255K
Operating Income -$3.8M
Selling General And Administrative $1.5M
Research And Development $1.9M
Operating Expenses $3.5M
Investment Income Net -
Net Interest Income -$147K
Interest Income -
Interest Expense $147K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $255K
Income Before Tax -$4.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$4.2M
Comprehensive Income Net Of Tax -
Ebit -$4M
Ebitda -$3.8M
Net Income -$4.3M

APM News

APM Profile

Aptorum Group Ltd Class A Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aptorum Group Ltd Class A is a London-based biotechnology firm dedicated to the discovery, development, and commercialization of innovative therapeutic solutions, with a primary focus on combating infectious diseases and various forms of cancer. The company boasts a robust pipeline of drug candidates, underpinned by cutting-edge research and proprietary technologies, which demonstrates its commitment to addressing significant unmet medical needs. With a strategic emphasis on rapidly advancing novel therapies to market, Aptorum Group is well-positioned to make a substantial contribution to the pharmaceutical industry and enhance patient outcomes.

VHAI
-17.50%
$0.00
MSPR
+172.68%
$0.59
NVDA
-0.19%
$202.49
EZGO
+16.87%
$0.15
ASST
+9.91%
$1.33
DVLT
-19.44%
$2.02
BURU
+0.26%
$0.33
BTG
-9.85%
$4.38
PLUG
+1.50%
$2.69
T
+0.28%
$24.75
DNN
-1.55%
$3.17
AAPL
-0.37%
$270.37
TSLA
+3.74%
$456.56
YGMZ
+7.85%
$0.13
AZI
+3.38%
$0.09
RIG
-1.79%
$3.84
F
+0.53%
$13.13
AXDX
-61.36%
$0.03
RGTI
+4.11%
$44.27
KVUE
+17.95%
$16.95
TGE
-53.70%
$0.77
NIO
+3.42%
$7.25
CIFR
+31.31%
$24.48
ADAP
-15.14%
$0.05
CRBU
+34.07%
$3.24
LUMN
-0.58%
$10.28
FEMY
+22.42%
$0.78
SNAP
+2.63%
$7.80
CCL
+1.76%
$28.83
GRAB
+0.50%
$6.01
BITF
+11.71%
$4.43
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QBTS
+2.63%
$37.06
BBD
-0.29%
$3.38
YDKG
+5.68%
$0.05
SRM
+53.27%
$10.30
LAES
+7.69%
$7.42
HPE
+0.04%
$24.42
WTO
+0.21%
$0.04
RIOT
-6.21%
$19.78
RNTX
+10.95%
$1.73
KDLY
+8.92%
$0.92
APLD
+2.09%
$34.65
AMZN
+4.44%
$255.08
KHC
+0.61%
$24.73
GOOG
-0.02%
$281.82
MRVL
+5.83%
$93.74
WLGS
-5.57%
$0.04
IREN
+19.98%
$72.89
SOUN
+4.44%
$17.62
IXHL
-6.56%
$0.37
ETWO
0.00%
$3.30
DXCM
-14.63%
$58.22
UUUU
-6.00%
$20.51
HL
-0.23%
$12.87
BYND
-11.96%
$1.45
CSCO
+0.27%
$73.11
AFMD
-34.94%
$0.18
FUBO
-10.88%
$3.36
PACB
+20.61%
$2.34
VIVK
+1.13%
$0.23
EPWK
-8.07%
$0.07
AGNC
+1.20%
$10.00
OPI
-16.97%
$0.20
FMC
-2.31%
$15.17
CMBM
-20.26%
$2.99
XOM
-0.28%
$114.36
WDC
+8.74%
$150.21
PLTD
-3.18%
$6.08
NVO
-1.15%
$49.46
KLG
-9.05%
$13.35
SMCI
+3.15%
$51.96
PBR
-0.68%
$11.64
GRYP
-10.38%
$1.38
MSAI
+19.74%
$1.86
DFLI
+12.72%
$1.24
MODV
-25.22%
$0.43
ARDX
+20.95%
$6.06
AREC
+15.84%
$4.46
METU
-5.43%
$32.20
RBLX
+0.63%
$113.72
BE
+3.37%
$132.16
IOVA
+0.76%
$1.98
ORCL
+2.22%
$262.61
KO
-0.11%
$68.90
FCEL
+15.78%
$8.94
MO
-1.31%
$56.38
WULF
+1.35%
$15.71
AG
-1.92%
$12.77
DKNG
+1.49%
$30.59
UBER
+0.01%
$96.50
RANI
+7.19%
$2.35
WFC
+1.13%
$86.97
SAND
-6.04%
$12.12
NOK
+3.03%
$7.12
MSTR
+5.86%
$269.51
SHOT
-74.37%
$0.39
INTS
-21.33%
$0.57
RKLB
+3.38%
$62.98
VHAI
-17.50%
$0.00
MSPR
+172.68%
$0.59
NVDA
-0.19%
$202.49
EZGO
+16.87%
$0.15
ASST
+9.91%
$1.33
DVLT
-19.44%
$2.02
BURU
+0.26%
$0.33
BTG
-9.85%
$4.38
PLUG
+1.50%
$2.69
T
+0.28%
$24.75
DNN
-1.55%
$3.17
AAPL
-0.37%
$270.37
TSLA
+3.74%
$456.56
YGMZ
+7.85%
$0.13
AZI
+3.38%
$0.09
RIG
-1.79%
$3.84
F
+0.53%
$13.13
AXDX
-61.36%
$0.03
RGTI
+4.11%
$44.27
KVUE
+17.95%
$16.95
TGE
-53.70%
$0.77
NIO
+3.42%
$7.25
CIFR
+31.31%
$24.48
ADAP
-15.14%
$0.05
CRBU
+34.07%
$3.24
LUMN
-0.58%
$10.28
FEMY
+22.42%
$0.78
SNAP
+2.63%
$7.80
CCL
+1.76%
$28.83
GRAB
+0.50%
$6.01
BITF
+11.71%
$4.43
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QBTS
+2.63%
$37.06
BBD
-0.29%
$3.38
YDKG
+5.68%
$0.05
SRM
+53.27%
$10.30
LAES
+7.69%
$7.42
HPE
+0.04%
$24.42
WTO
+0.21%
$0.04
RIOT
-6.21%
$19.78
RNTX
+10.95%
$1.73
KDLY
+8.92%
$0.92
APLD
+2.09%
$34.65
AMZN
+4.44%
$255.08
KHC
+0.61%
$24.73
GOOG
-0.02%
$281.82
MRVL
+5.83%
$93.74
WLGS
-5.57%
$0.04
IREN
+19.98%
$72.89
SOUN
+4.44%
$17.62
IXHL
-6.56%
$0.37
ETWO
0.00%
$3.30
DXCM
-14.63%
$58.22
UUUU
-6.00%
$20.51
HL
-0.23%
$12.87
BYND
-11.96%
$1.45
CSCO
+0.27%
$73.11
AFMD
-34.94%
$0.18
FUBO
-10.88%
$3.36
PACB
+20.61%
$2.34
VIVK
+1.13%
$0.23
EPWK
-8.07%
$0.07
AGNC
+1.20%
$10.00
OPI
-16.97%
$0.20
FMC
-2.31%
$15.17
CMBM
-20.26%
$2.99
XOM
-0.28%
$114.36
WDC
+8.74%
$150.21
PLTD
-3.18%
$6.08
NVO
-1.15%
$49.46
KLG
-9.05%
$13.35
SMCI
+3.15%
$51.96
PBR
-0.68%
$11.64
GRYP
-10.38%
$1.38
MSAI
+19.74%
$1.86
DFLI
+12.72%
$1.24
MODV
-25.22%
$0.43
ARDX
+20.95%
$6.06
AREC
+15.84%
$4.46
METU
-5.43%
$32.20
RBLX
+0.63%
$113.72
BE
+3.37%
$132.16
IOVA
+0.76%
$1.98
ORCL
+2.22%
$262.61
KO
-0.11%
$68.90
FCEL
+15.78%
$8.94
MO
-1.31%
$56.38
WULF
+1.35%
$15.71
AG
-1.92%
$12.77
DKNG
+1.49%
$30.59
UBER
+0.01%
$96.50
RANI
+7.19%
$2.35
WFC
+1.13%
$86.97
SAND
-6.04%
$12.12
NOK
+3.03%
$7.12
MSTR
+5.86%
$269.51
SHOT
-74.37%
$0.39
INTS
-21.33%
$0.57
RKLB
+3.38%
$62.98
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.